Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Long-Term Debt Repayments: 2015-2025

Historic Long-Term Debt Repayments for Editas Medicine (EDIT) over the last 2 years, with Mar 2025 value amounting to $2.9 million.

  • Editas Medicine's Long-Term Debt Repayments was N/A to $2.9 million in Q1 2025 from the same period last year, while for Mar 2025 it was $3.5 million, marking a year-over-year change of. This contributed to the annual value of $857,000 for FY2018, which is 12.17% up from last year.
  • Per Editas Medicine's latest filing, its Long-Term Debt Repayments stood at $2.9 million for Q1 2025, which was up 1,116.95% from $236,000 recorded in Q4 2018.
  • In the past 5 years, Editas Medicine's Long-Term Debt Repayments registered a high of $2.9 million during Q1 2025, and its lowest value of $2.9 million during Q1 2025.
  • Moreover, its 1-year median value for Long-Term Debt Repayments was $2.9 million (2025), whereas its average is $2.9 million.